Patent · US Active

Inhibitors of glucocorticoid receptor

US10723759B2 · kind B2 · utility

0Cited by
14References
28Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 5, 2019
Grant dateJul 28, 2020
Priority date
Expiry dateSep 5, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07J71/0015
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention relates generally to compositions and methods for treating cancer and hypercortisolism. Provided herein are substituted steroidal derivative compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for inhibition of glucocorticoid receptors. Furthermore, the subject compounds and compositions are useful for the treatment of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.